Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity

One adverse event was reported but was unrelated to the vaccine

One adverse event was reported but was unrelated to the vaccine

This post was originally published on The Asian Age | Home.


Print Share Comment Cite Upload Translate Updates
APA
The Asian Age | Home | radiofree.asia (2024-04-29T06:30:21+00:00) » Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity. Retrieved from https://radiofree.asia/2021/01/22/phase-1-trial-results-show-covaxin-has-tolerable-safety-enhanced-immunity/.
MLA
" » Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity." The Asian Age | Home | radiofree.asia - Friday January 22, 2021, https://radiofree.asia/2021/01/22/phase-1-trial-results-show-covaxin-has-tolerable-safety-enhanced-immunity/
HARVARD
The Asian Age | Home | radiofree.asia Friday January 22, 2021 » Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity., viewed 2024-04-29T06:30:21+00:00,<https://radiofree.asia/2021/01/22/phase-1-trial-results-show-covaxin-has-tolerable-safety-enhanced-immunity/>
VANCOUVER
The Asian Age | Home | radiofree.asia - » Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity. [Internet]. [Accessed 2024-04-29T06:30:21+00:00]. Available from: https://radiofree.asia/2021/01/22/phase-1-trial-results-show-covaxin-has-tolerable-safety-enhanced-immunity/
CHICAGO
" » Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity." The Asian Age | Home | radiofree.asia - Accessed 2024-04-29T06:30:21+00:00. https://radiofree.asia/2021/01/22/phase-1-trial-results-show-covaxin-has-tolerable-safety-enhanced-immunity/
IEEE
" » Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity." The Asian Age | Home | radiofree.asia [Online]. Available: https://radiofree.asia/2021/01/22/phase-1-trial-results-show-covaxin-has-tolerable-safety-enhanced-immunity/. [Accessed: 2024-04-29T06:30:21+00:00]
rf:citation
» Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity | The Asian Age | Home | radiofree.asia | https://radiofree.asia/2021/01/22/phase-1-trial-results-show-covaxin-has-tolerable-safety-enhanced-immunity/ | 2024-04-29T06:30:21+00:00
To access this feature and upload your own media, you must Login or create an account.

Add an image

Choose a Language



A Free News Initiative

Investigative Journalism for People, Not Profits.